Reciprocal control of genome instability and RNA processing in cancer: Mechanisms and therapeutic opportunities
Science Advances · 06.11.2026 · 12 (45)
DOI: 10.1126/sciadv.aei7541 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 06.11.2026. Verfasst von Mariachiara Grieco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hemato-Oncology, University of Milan, 20142 Milan, Italy. Hauptthemen laut MEDLINE: Genomic Instability, Neoplasms, RNA Processing, Post-Transcriptional. Die Arbeit nennt 225 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN.
Abstract (Originalsprache)
Genomic instability and dysregulated RNA processing are each recognized as core hallmarks of cancer, but accumulating evidence indicates that they are mechanistically intertwined rather than independent features. Chromosomal instability, mismatch-repair deficiency, and homologous recombination deficiency can reshape RNA splicing, 3′ end formation, and RNA surveillance through changes in gene dosage, DNA damage signaling, and alterations in regulatory elements. Conversely, aberrant splicing, polyadenylation, and RNA modifications can impair DNA repair, perturb mitotic control, and promote replication stress, thereby reinforcing genomic instability. This bidirectional circuit drives clinically relevant phenotypes, including therapeutic resistance, immune modulation, and emergent vulnerabilities that are not captured by DNA-centric biomarkers alone. Here, we present a unified framework for the genome instability–RNA processing axis and its direct clinical implications for cancer diagnosis, treatment stratification, and therapeutic exploitation, highlighting the most actionable mechanistic interfaces and discussing how integrated DNA-RNA biomarkers and rational combination strategies could extend precision oncology beyond static genomic lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oncology and Hemato-Oncology, University of Milan, 20142 Milan, Italy.
- Italian Institute for Genomic Medicine, c/o IRCCS, Str. Prov.le 142, km 3.95, 10060 Candiolo (TO), Italy.
- Department of Medical Oncology, Gustave Roussy, Villejuif, France.
- Center for OncoGenomics and Innovative Therapeutics (COGIT), Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Istituto Nazionale Oncologico Candiolo (INOC), IRCCS, Candiolo (TO), Italy.
- IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy.
ORCID-Profile: Mariachiara Grieco, Federica Giugliano, Ernesto Guccione, Ilio Vitale, Matteo Cereda
Förderung
- NCI NIH HHS
- National Cancer Institute
- Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN
- AIRC
- Compagnia di San Paolo Foundation.
- Associazione Italiana per la Ricerca sul Cancro AIRC
- CARESS Fondazione Piemontese per la Ricerca sul Cancro (FRPC) 5 × 1000 Intramural Grant
- Compagnia di San Paolo Foundation
Zitieren
APA
Grieco, M., Giugliano, F., Guccione, E., Vitale, I., & Cereda, M. (2026). Reciprocal control of genome instability and RNA processing in cancer: Mechanisms and therapeutic opportunities. Science Advances, 12(45). https://doi.org/10.1126/sciadv.aei7541
Vancouver
Grieco M, Giugliano F, Guccione E, Vitale I, Cereda M. Reciprocal control of genome instability and RNA processing in cancer: Mechanisms and therapeutic opportunities. Science Advances. 2026;12(45). doi:10.1126/sciadv.aei7541
BibTeX
@article{Grieco2026,
author = {Grieco, Mariachiara and Giugliano, Federica and Guccione, Ernesto and Vitale, Ilio and Cereda, Matteo},
title = {Reciprocal control of genome instability and RNA processing in cancer: Mechanisms and therapeutic opportunities},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {45},
doi = {10.1126/sciadv.aei7541}
}
EUVIMED